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SegmentationDNA copy number aberrations (CNAs) are genetic alterations common in cancer cells. Their transcriptional
consequences are still poorly understood. Based on the fact that DNA copy number (CN) is highly correlated
with the genomic position, we have applied a segmentation algorithm to gene expression (GE) to explore its
relation with CN. We have found a strong correlation between segmented CN (sCN) and segmented GE (sGE),
corroborating that CNAs have clear effects on genome-wide expression. We have found out that most of the
recurrent regions of sGE are common to those obtained from sCN analysis. Results for two cancer datasets
conﬁrm the known targets of aberrations and provide new candidates to study. The suggested methodology
allows to ﬁnd recurrent aberrations speciﬁc to sGE, revealing loci where the expression of the genes is
independent from their CNs. R code and additional ﬁles are available as supplementary material.l rights reserved.© 2010 Elsevier Inc. All rights reserved.1. Introduction
The presence of genomic aberrations in tumoral cells is a well-
known fact. In recent years, several studies have shown that the
alteration of DNA copy number (CN) can be related to similar
modiﬁcations in the expression levels of some speciﬁc genes [1–3].
These changes can be ampliﬁcations (gains) or deletions (losses) of a
region of a chromosome, or even a whole chromosome and they are
commonly called DNA copy number aberrations (CNAs). These
abnormalities are assumed to affect gene expression (GE) and
ultimately some of them may coadjuvate to the development of a
particular cancer. However, the relationship between CN and GE is
complex and not well understood: there are genes whose expression
is not apparently affected by their CNs and genes which show their
expression strongly correlated with them. One reason for this unclear
relationship is that CN is only one of the several factors that can affect
the regulation of GE and gene function in complex metazoans.
Recently, new studies focused on the relationship between CNAs
and GE have performed joint analysis based on different strategies.
Some of them calculated the correlation between CN and GE gene by
gene across samples [2,4,5]. These correlations are not particularly
large, although they are signiﬁcant for many genes. Others, like Tsafrir
et al. [6], obtained a correlation along the genome using ﬁltered CN
and ﬁltered GE. Witten et al. use a sparsiﬁed version of the canonical
correlation between CN and GE [7]. Moreover, Jarvinen et al. [8] and
Cifola et al. [9] based their experiments on differential expressioncalculated between groups deﬁned by genomic alterations. Finally,
other studies are based on the hypothesis that some genes are
grouped in the genome by their functions and, because of this, they
consider that CNAs affect groups of cofunctional genes [10,11].
Here, we hypothesize that there should be a common behavior of
the genes under the inﬂuence of CNAs. From this viewpoint we look
for a global consistent relationship between CN and GE. Knowing that
CNAs are highly correlated with the position on the genome, we
propose that the global GE modiﬁcations produced by CNAs should be
also correlated with the genomic position.
In order to study and evaluate the relationship between CN and GE,
we have used a global approach that does not focus only in gene by
gene relationships but that considers the complete genome and treats
the loci with a coherent common approach, both when measuring CN
and transcriptomic activity. To test the validity of our hypothesis, we
have analyzed two different set of samples that have matched CN and
GE. One of them is a study of glioblastoma multiforme (GBM) [2] and
the other is a study of acute lymphoblastic leukemia (ALL) [3].
Since the CN values of two adjacent positions in the genome are
(unless there is a CNA) identical, segmentation of raw CN improves
the estimation of real CN. The segmentation algorithm (in the case of
CN) identiﬁes contiguous subsets of SNPs in the genome that have the
same CN value. It provides “sharp” edges between regions instead of
smooth transitions as standard ﬁlters do. This characteristic is
important when working with CN data because when a region is
lost (or ampliﬁed) the change between the two sides of the break
point is not smooth. Therefore, the segmentation methods applied to
raw CN data (sCN) give better results than linear or median ﬁlters [12]
and they are customarily applied. We applied a similar segmentation
approach (in the two datasets) to both analysis (GE and CN). Applying
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possible effects of the regulation of GE that are not related with the
genomic position. We found that segmented values of GE (sGE) are
strongly correlated with sCN.
Finding recurrent aberrations in segments of the genome has been
an active ﬁeld of research on the last years [13]. Copy number data can
be used to ﬁnd chromosomal regions in which aberrations (deletions
or ampliﬁcations) frequently appear. It is essential to ﬁnd the
recurrent changes in samples to get a common CNA signature of a
given disease. In cancer, full agreement within tumor samples is
difﬁcult to ﬁnd due to tumor heterogeneity. However, if there is a
consistent region of aberration which happens more often than
expected by chance, it could reveal one of the causes of the detected
cancer. These chromosomal regions might include genes which
change their expression because of these CNAs and they would be
also found as recurrent using sGE data. The recurrent aberrated
regions in sCN and sGE in this work have been independently
calculated and the results show that most of them appear in the same
cytobands in sGE and sCN.Fig. 1. Analysis work ﬂow for CN and GE. The gene expression arrays are processed with
summarization of the probes is done using a speciﬁc cdf which has the information on how t
data). Once the data have been processed, a segmentation algorithm is applied dividing th
assigning a single value, log2 ratio of CN for SNPs and log2 ratio of expression for genes. SN
explained in the main text. Once both identiﬁers are matched, we have computed the co
similarities between regions over/under expressed and regions with gain/loss of copy numb
segmented data (sCN and sGE) in order to ﬁnd altered loci in a signiﬁcant group of samples aContrary to this general trend, in some cases we found genome
regions or loci where CNAs do not correlate with GE changes, for
example where the sGE is signiﬁcantly altered but the sCN is neutral.
These regions can be affected by another level of regulation, e.g.,
epigenetic methylation/demethylation, or occur in zones with
recurrent copy neutral loss of heterozygosity (LOH) [14,15]. However,
in our datasets, we did not ﬁnd a conclusive evidence of this effect.
The calculation of sGE using expression microarray data can be, on
its own, an interesting approach to putatively pinpoint loci in the
genome affected by different positional factors, such as alteration in
the number of copies, epigenetic modiﬁcations, LOH or other events
linked to the position in the genome.2. Materials and methods
The analysis of the arrays can be divided into two different parallel
processes for CN and GE. Fig. 1 outlines the steps followed in this
research.RMA [16] and the SNPs copy number arrays are analyzed using CRMAv2 [17]. The
o group the probes (by genes in the case of expression data or by SNPs for copy number
e genome in regions of consecutive elements (SNPs or genes) with similar values and
P CN and gene expression data can be matched using their locations in the genome as
rrelation (that was strongly signiﬁcant) and generated the ROC curves that show the
ers. Finally, GISTIC, an algorithm to detect recurrent aberrated regions is applied to the
nd the results are compared. Pipelines for CN and GE data are completely independent.
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Two different studies have been used to validate our method. Both
include measurements of genome-wide copy number and expression
for each sample. The ﬁrst dataset is a study of brain tumors carried out
by Kotliarov et al. [2]. We used a subgroup of 64 cases (listed in the
supplementary material) from the whole dataset related with
glioblastoma multiforme (GBM). The second dataset consists of 28
cases of pediatric acute lymphoblastic leukemia (ALL) from the
GSE10792 [3]. These leukemia samples are listed in the supplementary
material.
2.2. Material and data preprocessing
Gene expression data have been analyzed using RMA [16] over the
HGU133 plus2 array. The chip deﬁnition ﬁle (cdf) to perform the
analysis was downloaded from version 10 of Brainarray [18], which
corresponds to version 46 of Ensembl genes and genomes.
Affymetrix Human Mapping 50K SNP array has been used for the
analysis of the CN data. The cdf ﬁle needed in this case is the Affymetrix
GeneChipMapping 50K Xba240_SNP array cdf. CRMAv2 [17] has been
applied to the CN signals in order to obtain the raw CN.
The analysis of both types of data have been performed under R
[19] using the aroma.affymetrix package [20].
2.3. Segmentation
A segmentation algorithm divides a set of ordered data into
regions of adjacent elements which have similar values. Each region is
assigned a single value which represents all the data that belong to it.
Segmentation methods are a family of algorithms that were initially
applied to image analysis and, more recently, to genomic data.
There are several algorithms to segment genomic data such as
circular binary segmentation (CBS) [21,22], CGHseq [23], GLAD [24] or
HAAR [25], among others.
CBS has been chosen in this experiment because different
independent comparisons [12,26] have proved that it is an accurate
method. It is also widely used and implemented both in Matlab and R.
Before the segmentation algorithm is applied, the raw data are
normalized dividing by the median of the samples from each element
(SNP or gene) and computing its log2,
Δ CNi; j = log2 CNi; j =median CNi;1:n
  
ð1Þ
Δ GEk; j = log2 GEk; j =median GEk;1:n
  
; ð2Þ
where i and k represent the elements (SNPs or genes, respectively), j
is the sample and n is the number of samples analyzed in the
experiment.
The input of the segmentationmethods are the raw data (i.e., GE or
CN values previously calculated) and a list with the name, chromo-
some and position of each of the probesets of the array.
CBS proceeds as follows. It considers each of the chromosomes as a
“ring”: both extremes of the chromosomes are assumed to be
connected. Each ring is split in two parts and the copy numbers of
each of these parts are compared using a t-test
Zij =
Sj−Si
 
= j−ið Þ− Sn−Sj + Si
 
= n−j + ið Þ
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for each pair of positions i, j. Sn is the sum of the raw copy number data
from the 1st SNP to the nth SNP. The method is based on the statistic
ZC=max 1b ib jbn|Zij|. If the ZC is above a threshold, established using a
bootstrap method, then a new segment is found. The same algorithm
is applied recursively to each of the found segments.Using bootstrap to select the threshold is time-consuming. The
authors of CBS derived an estimation of the threshold one order of
magnitude faster [22]. Recently, they have developed an even faster
version.
The output of the segmentation method is sGE and sCN for gene
expression and copy numbers. respectively. sGE and sCN are matrices
with constant values along the positions in the genome for points
(genes or SNPs) within the same segment.
As shown in Eq. (2), each gene is previously normalized by the
median of its expression across the samples. Therefore, sGE provides
regions of the genome that show their expression upregulated or
downregulated if compared with the median across the samples. sCN
has been normalized in a similar way.
Segmentation of GE shows a speciﬁc problem that does not occur
with CN data: a gene is itself a “segment” of the genome, not a single
point, as with a SNP. RMA (like other summarization algorithms)
provides an estimation of the concentration of the whole gene and as
indicated before, a segmentationmethod needs a ﬁle with the position
of the elements. Then, when dealing with GE data, a single position
point has to be assigned to each gene. We decided to use the middle
point of the genes as their representative positions (this middle point
is calculated for each gene as: genemiddlepos =(geneendpos+genestartpos )/2).
Most of the segmentationmethods are able to adapt their accuracy
according to the noise level of the data: if the data is clean, narrower
segments can be detected. If the data is noisier, only broad segments
are statistically signiﬁcant. Since GE is affected by other factors
different from CN, GE data is noisier than CN data and the
segmentation algorithm is expected to provide broader segments.
We used CBS algorithm with the default parameters for GE
segmentation, adapting the input data to the gene signals as indicated
above. The genome information of the genes was generated using
ENSMART [27]. The ﬁle and the code to generate it are included as
supplementary material.
2.4. Recurrent aberrations in chromosomal segments
There are different algorithms to ﬁnd recurrent segments with
aberrations such as STAC [28], SIRAC [29] or GISTIC [30], among
others. For a review of different methods, the reader can consult [31].
All of them, based on different statistical techniques, look for regions
with aberrations that occur in a signiﬁcant number of samples.
We have selected GISTIC [30] for our study. GISTIC is a freely
available method that distinguishes random background from true
aberrations. It takes into account the values of CN and lets the user set
the different parameters to ﬁnd deletions/ampliﬁcations and the
p-value to determine if an aberration is recurrent.
GISTIC, after a careful analysis of the samples (to exclude
duplicates or noisy samples), accepts as input sCN values. In its ﬁrst
stage, a statistic for each SNP is computed as follows:
Gampi =
1
n
∑cijI cij N θ
amp
 
; ð4Þ
where cij is the log2 ratio of the CN, I is an indicator function that
equals 1 if its argument is true and 0 otherwise, and θamp is a
threshold to consider that a locus has an ampliﬁcation. This statistic
takes into account both the strength of the ampliﬁcation as its
frequency. Using a semi-exact approximation, to avoid a computer
intensive bootstrap, GISTIC identiﬁes the regions of the genome were
Gi
amp is statistically signiﬁcant, with FDR correction for multiple
hypothesis. Once the recurrent regions are selected, GISTIC identiﬁes
the peak or peaks (if the region shows a multimodal distribution).
Genes that are located in these peaks are suggested by GISTIC to be the
targets of the recurrent ampliﬁcations. The same algorithm is used to
identify the deletions.
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we also applied it to sGE to ﬁnd recurrent over-expressed or under-
expressed regions in the genome. The thresholds established for this
experiment are the default values in GISTIC. As a result, GISTIC returns
a list of the recurrent regions with their statistical signiﬁcances.
2.5. Matching DNA copy number and gene expression data
The process to match both identiﬁers (genes and SNPs) is not
straightforward because there are genes that have several SNPs in the
array and there are genes with no SNPs. Moreover, there are SNPs in
the intergenic regions that do not match any gene coding region.
Our ﬁrst attempt was a direct assignation using Ensembl database
[32]. Only the genes that had SNPs assigned in the database were
matched and if there was a CNA within a gene, the median of the CN
values for all the SNPs belonging to that gene were calculated. With
this assignation only 50% of the genes had at least one corresponding
SNP in the SNP array. This loss of data drove us to use a different
approach.
Considering the sCN, the whole genome is divided into regions
depending on their sCN values. Then, using the position of a gene,
their corresponding sCN value can be assigned. So, even if a gene has
no SNPs, it always lies in a region that has a predicted sCN (by the
segmentation method). Fig. 2 illustrates this point. Gene A is located
in a segment of the genome with several SNPs mapped to it and a
single CN estimation (signal about −0.5). This is the CN value
assigned to gene A. Gene B has no SNPs located close to it, but the zone
of the genome where it is located has an assigned CN value. Finally,
gene C belongs to two different segments. In this last case, we have
considered the CN of a single point for each gene located at the center
point of its genomic position.
3. Results
As indicated in Section 2, we have used two different datasets of
cancer samples that have matched CN and GE data from genomewide
microarrays. One dataset is from a GBM study and the other one from
an ALL study. Since both studies have matched samples, we have
compared sGE with sCN with two different validation methods.
Firstly, we have generated a sCNmatrix with the dimensions genes by
samples in order to check if the CNAs affect the sGE. We have done
this using ROC curves. And the second method uses GISTIC to look for
recurrent aberrated regions in each of the data-types and check the
similarities and differences within the results.Fig. 2.Mapping between genes and sCN regions. This step is performed in order to assign a CN
ratio of the CN are represented and on the X axis the genomic position. The green dots are the
the dotted black lines are the “expected” values of a gain to three copies (log2(3/2) = 0.58), a
these values are not obtainedwhenusing real CNdata, this can be due to saturation of the prob
segmented, the genome is divided into regions of SNPs with an assigned number of copies. A
position. The procedure for different cases is indicated in the ﬁgure: gene A includes several S
estimated using the segmented data; ﬁnally, gene C displays a possible problem because ther
within a gene we have simply assigned the CN that corresponds to the center point of the gFigs. 3 and 4 show the results from both datasets. Both ﬁgures
show the recurrent ampliﬁed regions (red) and the recurrent over-
expressed zones (pink). In GBM (Fig. 3), there are regions such as
chromosomes 10, 19, 20 and 22 which are ampliﬁed and over-
expressed and all of them have been previously published in different
articles [33,35]. The recurrent deleted and under-expressed regions
from GBM are shown in Fig. 3 in dark and light green (negative part of
the plot). For example, arm 4q and regions 6q25, 11p15, 14q and
19p13 have been described as LOH regions because of the deletions
[14,15]. All of the LOH regions seem to affect the GE of genes lying in
those zones of the genome. On the other hand, there are some
recurrent CN aberrated regions that do not seem to affect sGE. This can
be due to the fact that they are so small that they are missed by the
segmentation method, or because these regions are regulated by
other factors that minimize the effect of CN.
From the ALL data we can see in Fig. 4 that chromosomes 4, 6, 14,
17, 18, and 21 are ampliﬁed and also found as recurrently over-
expressed. Small regions of arm p of chromosomes 7, 16 and 19 are
also selected using both types of data. Chromosome 1 seems to have
some genes over-expressed independently from sCN. The negative
part of the ﬁgure shows common aberrations in chromosome arms 7p,
9p, 20q and the whole chromosome 21. These regions are both
recurrently deleted and under-expressed. There are also some
recurrent CN aberrated regions that do not seem to affect sGE.
3.1. Similarities between sCN and sGE
After performing thematching between sCN and sGE, both types of
data have the same dimensions (genes by samples). The Pearson
correlation coefﬁcient between them in GBM was 0.60, with a strong
statistical signiﬁcance (pb2.210−16). Correlation for the ALL dataset
was weaker (0.19) but still strongly signiﬁcant (pb2.210−16).
Figs. 5 and 6 show the ROC curves for three different tests. These
tests check how CNAs affect sGE based on ROC curves. Firstly, we
generated a ROC curve to test if the CN ampliﬁcations affect sGE. In
order to do this, we considered that there was an ampliﬁcation if the
measured CN was larger than 2.5. This threshold (for all the samples)
gave a set of loci that showed ampliﬁcations. After that, different
thresholds for sGE data were set. Then, for a particular threshold there
were true positives (TP, i.e., loci with ampliﬁcations and also over-
expressed), false positives (FP, i.e., loci over-expressed and not
ampliﬁed) and, with equivalent deﬁnitions, true negatives (TN) and
false negatives (FN). Having these values, the true positive rate (TPR)
and the false positive rate (FPR)were calculated as: TPR=TP/(TP+FN)
and FPR=FP/(FP+TN). Second, the same reasoning was applied tovalue to each gene and test howboth (CN andGE)matrices behave. On the Y axis the log2
raw copy number values, the black horizontal lines are the segmented copy numbers and
normal region (log2(2/2) = 0) and a deletion to one copy (log2(1/2) =−1). However,
es, normalizationmethods or contaminationwith normal tissue. Once the CNshave been
fter that, the assignation of a CN value to each gene is performed based on its genomic
NPs which belong to a region of the segmentation; gene B has no SNPs but its CN can be
e are two regions with different CN values within it. In this experiment, if there is a CNAs
ene.
Fig. 3. Output of the GISTIC package for the GBM dataset using sCN and sGE. One of the outputs of GISTIC is a ﬁle where the recurrent regions it founds are assigned a g-score (value
calculated by GISTIC related to the q-value). In this ﬁgure the positive part of the Y axis represents the g-scores given to the ampliﬁed/over-expressed regions and the negative part
represents the (−)g-scores given to the deleted/under-expressed regions. We have done this change of sign in order to show both graphs in the same ﬁgure. On the other hand, the
X axis represents the genomic position grouped by chromosomes. There also are four horizontal lines that show the thresholds to consider a g-score signiﬁcant (FDR equals to 25%).
The two straight lines highlight the threshold corresponding to sCN, and the dotted lines highlight the ones corresponding to sGE. Depending on the aberration under study
(ampliﬁcations/over-expressions, deletions/under-expressions) they are respectively plotted in the positive and negative part of the ﬁgure. Only the autosomes are shown here. The
positive part of Fig. 3 shows the values obtained using GISTIC with both types of data. It shows the recurrent ampliﬁed regions (red) and the recurrent over-expressed zones (pink).
Regions such as chromosomes 10, 19, 20 and 22 are ampliﬁed and over-expressed and all of them have been previously published in different articles [33,34]. The recurrent deleted
and under-expressed regions are shown in Fig. 3 in dark and light green (negative part of the plot). For example, arm 4q and regions 6q25, 11p15, 14q and 19p13 have been
described as a LOH regions [14,15] and all of them seem to affect the GE of genes lying in those zones of the genome. On the other hand, there are some recurrent CN aberrated
regions that do not seem to affect sGE, this can be due to the fact that they are missed by the segmentation method, because of the large level of noise, or because these regions are
regulated by other factors that minimize the effect of CN. The Y axis were clipped to 0.2 and−0.2 to ease the comparison with the other dataset. The (maximum, minimum) values of
the g-scores for sCN and sGE are (0.880, −0.391) and (0.426, −0.140) respectively. The names of chromosomes 17, 19 and 21 are omitted owing to lack of space.
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or lower than 1.5). Finally, a third test to check strong ampliﬁcations
(four or more copies) is also performed. These ﬁgures also include a
ROC curve obtained using raw GE (instead of sGE) to test gains.
Fig. 5 shows for all the curves that use sGE, a high TPR (around
0.70) compared to a much lower (less than 0.05) FPR. These curvesFig. 4. GISTIC applied to the ALL data. In this ﬁgure the positive part of the Y axis represe
represents the (−)g-scores given to the deleted/under-expressed regions. Depending on the
they are respectively plotted in the positive and negative part of the ﬁgure. As in Fig. 3, the r
pink, while the recurrent deleted and under-expressed regions are shown in dark and ligh
expressions in both sCN and sGE. Chromosomes 4, 6, 14, 17, 18 and 21 are ampliﬁed and also
19 are also selected using both types of data. Chromosome 1 seems to have some genes o
aberrations in chromosome 7 and 9 arm p, chromosome 20 arm q and the whole chromos
clipped to 0.2 and−0.2. The (maximum, minimum) values of the g-scores for sCN and sGE a
are omitted owing to lack of space.show a very steep slope for low values of FPR in contrast to the ROC
curve obtained using raw GE. They can be interpreted as follows:
there are very few loci that show changes in sGE that do not directly
correspond to CNAs, i.e., most of the changes in sGE occur due to a
change in the CN (although there are some exceptions). However,
there are some CNAs that do not show the corresponding alteration innts the g-scores given to the ampliﬁed/over-expressed regions and the negative part
aberration under study (ampliﬁcations/over-expressions, deletions/under-expressions)
ecurrent ampliﬁed regions are shown in red and the recurrent over-expressed zones in
t green (negative part of the plot). In this ﬁgure we see recurrent amplifcations/over-
found as recurrently over-expressed. Small regions of arm p of chromosomes 7, 16 and
ver-expressed independent from sCN. The negative part of the ﬁgure shows common
ome 21. These regions seem to be both deleted and under-expressed. The Y axis were
re (0.189,−0.370) and (0.200,−0.188) respectively. Chromosome names 17, 19 and 21
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Fig. 5. Using the GBM dataset, we have calculated the ROC curves of the CNAs
(ampliﬁcations (copy number equal or higher than 2.5), deletions (copy number equal
or lower than 1.5) and high ampliﬁcations (four or more copies)) that also appear in
sGE, and also the same analysis using raw GE. The AUC (area under curve) using raw GE
is much smaller than using sGE. Ampliﬁcations and high ampliﬁcations strongly affect
sGE.
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curve approaches 1.0 only for large FPRs. The origin of this fact is two-
fold. On one hand, the segmentation algorithm over GE cannot
discover narrow segments because of the inherent variability of GE
owing to the different regulators. And, on the other hand, not all the
CNAs affect GE, and some genes (that do show aberrations in their CN)
are regulated by other factors that minimize the effect of CN.
In Fig. 6 the ROC curves obtained from the ALL dataset are shown.
As happens in GBM, here the ROC curves demonstrate that the0.0 0.2 0.4 0.6 0.8 1.0
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Fig. 6. As done before with GBM, this ﬁgure presents the ROC curves of the predictions
of CNAs (ampliﬁcations (copy number equal or higher than 2.5), deletions (copy
number equal or lower than 1.5) and high ampliﬁcations (four or more copies)) using
segmented gene expression data, and the predictions of ampliﬁcations using raw
expression data of pediatric acute lymphoblastic leukemia (ALL). TPR (correctly calling
CNAs aberrations) is around.9 for a FPR (incorrectly calling CNAs normal (CN=2))
equal to 0.02 for ampliﬁcations and high ampliﬁcations (black dots and red crosses).
When using raw expression data (green squares) the line we get is almost diagonal.aberrations (deletions, ampliﬁcations and high ampliﬁcations) are
reﬂected in segmented GE more than in raw GE. TPR (correctly calling
CNAs aberrations) is around 0.9 for a FPR (incorrectly calling CNAs
normal (CN=2)) equal to 0.02 for ampliﬁcations and high ampliﬁca-
tions (black dots and red crosses). This means that 90% of all the “real
CN ampliﬁcations” are found using segmented gene expression, or
that almost all the regions that are ampliﬁed are also over-expressed.
In the case of deletions (blue triangles), the slope is a bit lower andwe
get a TPR of almost 0.8 and a FPR of 0.09. When using raw expression
data (green squares) ROC curve is only slightly above the diagonal, i.e.,
results are only slightly better than those expected by chance.
3.2. Recurrent aberrated regions in sCN and sGE data
Usually researchers are interested in the location of recurrent
CNAs, i.e., ampliﬁcations or deletions, because they can be the drivers
of pathology. In our case, we have used GISTIC to provide the locations
of the genome especially enriched in over/under expressions (using
sGE data) and also in ampliﬁcations/deletions (using sCN data).
Figs. 3 and 4 show the g-scores provided by GISTIC for ampliﬁed/
over-expressed loci (red lines, positive part of the plot) and deleted/
under-expressed (green lines, negative part of the plot). It can be seen
that the signiﬁcant recurrent regions (if sCN and sGE are compared)
are very similar to each other, i.e., most of the recurrent aberrations
affect sGE and most of the recurrent over/under-expressed loci of the
genome are related with recurrent aberrations. The list provided by
GISTICwith themost signiﬁcant aberrated loci and a table showing the
statistical ratios at different thresholds are given as supplementary
material.
3.2.1. Common recurrent altered regions to sCN and sGE
In this section, we illustrate that the regions selected by GISTIC as
recurrently over/under-expressed using sGE are consistent with the
results from sCN, and also with the information already published
about GBM. GBM is the ﬁrst cancer sequenced by The Cancer Genome
Atlas (TCGA [35]) andwe have compared our ﬁndings with the results
published by this consortium.
In the case of common regions to both analysis, it is likely that the
reason for the changes in GE are the CNAs, i.e., regions with a deletion
tend to be under-expressed and regions with a gain tend to be over-
expressed.
Fig. 3 shows that most of the regions selected as recurrent using
sCN also appear with sGE data. We independently study both the
deletions/under-expressions and the gains/over-expressions.
3.2.1.1. Recurrent deleted and under-expressed regions. In this section
we focus on the recurrent deleted and under-expressed regions
shown in Figs. 3 and 4 in dark and light green (negative part of the
plot).
3.2.1.1.1. GBM. Arm 4q and regions 6q25, 11p15, 14q and 19p13
have been described as deleted regions [14,15] and all of them seem to
affect the GE of genes lying in those zones of the genome. The
chromosome arm 4q has also been studied as a loss region [36,37]
which can be the reason for the change in the GE data.
McLendon et al. [35] describe region 9p21.3 as the most
recurrently deleted in GBM, and we show that it is also recurrent in
segmented gene expression data as an under-expressed zone. PTEN
(10q23.31) is known to bemutated in GBM and to have a homozygous
deletion in a high percentage of samples [30,35]. Arm 15q has been
reported to be deleted in GBM samples in a study performed by
Vranova et al. [38]. Region 13q14 [35] and 22q13 [39] have been
reported to be related with the progression of the GBM. All these
regions appear to be recurrently under-expressed and deleted in our
study.
3.2.1.1.2. ALL. In this dataset, the analysis of the ALL samples based
on recurrent deleted/under-expressed regions (Fig. 4) shows that
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sGE data. In this way, there is a clear agreement between our analyses
and the results published by Bungaro et al. [3]. However, in our
dataset we detect higher frequencies of the 9p deletion than Bungaro
et al.
3.2.1.2. Recurrent ampliﬁed and over-expressed regions. The positive
part of Figs. 3 and 4 show the recurrent ampliﬁed and over-expressed
regions obtained using GISTIC with both datasets respectively. It
shows the recurrent ampliﬁed regions (red) and the recurrent over-
expressed zones (pink).
3.2.1.2.1. GBM. Regions such as chromosomes 10, 19, 20 and 22 are
ampliﬁed and over-expressed and all of them have been previously
published in different articles [34].
Gene EGFR, located at 7p11.2 has been previously found to have
been activated in glioblastomas [30,35] and here it appears as
recurrent in both sCN and sGE data. A narrow region in 1q32 has
been reported as an ampliﬁcation related with the progression of the
gliomas [40]. Weber et al. [33] also associated region 5q34 with the
proliferative activity of malignant glioma cell lines.
CDK4 on 12q14 is frequently ampliﬁed in GBMs [41]. Knobbe et al.
[42] and Van et al. [43] reported region 13q34 as ampliﬁed and over-
expressed. Finally, Korshunov et al. [44] described cytoband 14q32 as
a frequently ampliﬁed region in GBMs.
3.2.1.2.2. ALL. Fig. 4 shows that chromosome 21 suffer one of the
clearest alteration with a signiﬁcant gain that can be also seen in sGE
data too. Again, there is an agreement between our analyses and the
results published by Bungaro et al. [3]. The “chr 21 ampliﬁcation”
affects 64.2% of the cases. Moreover, the method here proposed also
allows to detect signiﬁcant alterations in other chromosomes that
were not indicated by Bungaro et al. and that also occur in both data
types (sCN and sGE), as the gain of chromosomes 6, 17 and 18 (see
Fig. 4) which have already been published [45].
3.2.2. Noncommon recurrent altered regions
In addition to the over/under-expressed regions caused by CNAs,
there are zones in sGE which appear to be correlated with the position
in the genome but not with the observed CNAs. These regions can
appear due to other causes different from sCN (as methylation, LOH
with neutral copy number or clusters of genes regulated for the same
factor). In our case, a LOH analysis (for loci with neutral CN) was
executed and no signiﬁcant results were found.
3.2.2.1. Recurrent over/under-expressed regions
3.2.2.1.1. GBM. The closest gene to region 15q21.1 is THBS1 which
appears to be under-expressed. It has been identiﬁed as a methylated
tumor suppressor in different cancers [46]. This fact could be the
reason why this region appears more clearly when studying sGE than
with sCN. There also are a group of loci where different gene families
are located that seem to have their expression altered, as MT1 gene
family (16q12.2), IRX (5p15.33), NEF (8p21.2) and CXC (4q13.3).
These results can be due to a common regulation factor that impacts
the whole gene family and can be found using sGE.
3.2.2.1.2. ALL. In the ALL data there are also a number of genomic
regions which seem to have the genes within them be affected by a
factor related with the position in the genome. These regions are
mostly in chromosomes 1, 5, 13 and 19, and most of them have
already been studied [47,48].
4. Discussion
In this study, we propose to segment GE data derived from
genome-wide expression microarrays. Segmentation of gene expres-
sion tends to reduce the effects not related with the position in the
genome: if the regulators are not related with the genomic position,
upregulation and downregulation of close genes along the genomewill tend to cancel out each other. Therefore, sGE is an indirect
measurement of the effect on GE of the regulators related with the
genomic position. In Section 3, it is shown that one of the effects
related with the genomic position and in fact the most important one
is CNA.
None of the datasets (both GBM and ALL) includes reference
samples. The normalization of the CN and GE estimates has been done
using the median of all the samples. This method is valid if most of the
samples behave normally. However, in the case of very frequent
aberrations, the value of this reference can be biased towards the
direction of the alteration. This is the reason why, for example,
chromosome 7 in the GBM dataset appears to be both recurrently
deleted and ampliﬁed (when it is known to be ampliﬁed in GBM). If
the studies include reference samples it is advisable to use them both
for CN and GE normalization, i.e., in Eqs. (1) and (2), the median that
appears in the denominator must be performed over the reference
samples instead of all the samples.
sGE and sCN data have a close relationship as shown by the global
correlation between sGE and sCN which is strongly signiﬁcant. In
addition, the ROC curves of the CNAs and sGE show that, depending on
the threshold, it is possible to get speciﬁcities and sensitivities over
75% (Figs. 5 and 6). Figs. 3 and 4 also show that most of the recurrent
aberrated regions commonly occur in both types of data.
GE, as expected, has a very strong variation across the genome
since many factors that affect GE are not related with the genomic
position. This additional variability is reﬂected in the probabilities of
recurrent aberrations. As can be seen in Fig. 3, g-scores for sCN are
larger (more signiﬁcant) than for segmented expression data. Even
though, the predicted recurrent regions are very similar and the
overall probabilities provided by sGE are signiﬁcant. We have also
found recurrent “under-expressed segments” not correlated with “CN
deletions.” These discrepancies can be attributed to local modiﬁca-
tions of the genome, for example, a local methylation of the genome as
has been published by Stransky et al. [49] located in one of these zones
where CNA and GE do not correlate. Other loci not regulated by CN are
gene families affected by a common regulation factor.
In summary, at least for an exploratory analysis, sGE provides
initial regions to search for possible target genes whose CNAs affect
GE. In addition, the combination of sGE and sCN also provides loci
uncorrelated GE/CN that can be related to other regulatory events.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ygeno.2010.10.008.
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